As a Texas Urology Specialists patient, you may have the opportunity to receive newly-developed treatments or investigational drugs through participation in clinical trials. Although they are unproven, new treatments and drugs may result in the alleviation of your symptoms.
To receive these experimental treatments, you will likely be required to participate in research studies or clinical trials. These clinical trials are designed to evaluate new treatment options as part of a deliberate and comprehensive research process that often takes years. Clinical trials test the safety and effectiveness of new or modified treatments in patients using new drugs, unique approaches to surgery and radiation therapy, or various combinations of treatments.
If you are interested in learning more about Research and Clinical Trials and if you qualify, please review the list of available trials below and discuss those options with your Texas Oncology Physician.
Are you a man over the age of 50 with symptoms of an enlarged prostate such as slow urinary stream, urgent or frequent urination and/or getting up at night to urinate? If so, you may qualify for one of two research studies. If you are not taking either Proscar or Avodart, and have not had prostate surgery you are potentially a candidate for one of our BPH trials.
If interested call Debbie at 713-357-0554 or 713-932-1819.
Are you getting up at night to urinate 2 or more times on average? If so, you are suffering from nocturia. Treatment options at present have had only modest success. We are studying a medication for treatment of this troubling condition.
If you would like to consider participating in a trial to treat nocturia, please call Debbie at 713-357-0554 or 713-932-1819 to see if you qualify.
Overactive Bladder (OAB)
If you are at least 18 years old, urinating 8 times or more and have accidents due to urgency at least twice a day, have not been treated with OAB meds more than 3 times a year, you might qualify in our study.
Please call Debbie at 713-357-0554 or 713-932-1819.